Skip to main content
. 2019 Oct 29;44(6):2276–2288. doi: 10.3892/ijmm.2019.4386

Table II.

Association between RFC3 expression and clinicopathological characteristics of 123 patients with lung adenocarcinoma.

Variables RFC3 expression
Total χ2 P-value
Low expression High expression
Total cases 66 57
Sex 0.012 0.914
 Male 26 23 49
 Female 40 34 74
Age 0.879 0.349
 ≤60 years 38 28 66
 >60 years 28 29 57
Smoking history 2.897 0.089
 Yes 27 15 42
 No 39 42 81
TNM stage 6.409 0.011a
 Stage I-II 60 42 102
 Stage III-IV 6 15 21
Differentiation 5.139 0.023a
 Well 39 22 61
 Moderate/poor 27 35 62
Size 2.328 0.127
 ≤3 cm 49 35 84
 >3 cm 17 22 39
Node status 5.747 0.017a
 Positive 9 18 27
 Negative 57 39 96
a

P<0.05, Pearson χ2 test. RFC3, replication factor C subunit 3.